Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.57 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.57 |
| ▸ | PKM | P14618 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | TNF | P01375 | 1/20 | 0.51 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.51 |
| ▸ | RBBP9 | O75884 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194739 | 1.00 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL12328529 | 0.92 | SMN1; SMN2 (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL10779103 | 0.92 | SMN1; SMN2 (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL20278523 | 0.87 | KMT2A (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL195166 | 0.87 | KMT2A (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL195165 | 0.87 | KMT2A (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| Acetone SCHEMBL28800731 | 0.85 | KMT2A (0.60) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL92008 | 0.84 | SMN1; SMN2 (0.79) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL92110 | 0.83 | SMN1; SMN2 (0.57) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL1357956 | 0.82 | MAPT (0.78) | SMN1; SMN2MAPTCDK5CDK5R1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080188474-A1 | e.g. 1-phenyl-N3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-1,2,4-triazole-3,5-diamine; receptor protein tyrosine kinase (AXL) antagonist; antiinflammatory, anticarcinogenic , antidiabetic agent; rheumatoid arthritis, vascular disease; breast, renal, endometrial, ovarian carcinoma, or myeloid leukemia | RIGEL PHARMACEUTICALS, INC. (US) | 2008-08-07 | — | — | US | claimed |
| EP-0520364-B1 | Photopolymerizable composition | FUJI PHOTO FILM CO LTD (JP) | 1997-09-17 | — | — | EP | claimed |
| EP-0377321-B1 | Photopolymerizable composition | FUJI PHOTO FILM CO LTD (JP) | 1995-03-22 | — | — | EP | claimed |
| US-5385807-A | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1995-01-31 | — | — | US | claimed |
| EP-0520364-A1 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-30 | — | — | EP | claimed |
| EP-0377321-A2 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1990-07-11 | — | — | EP | claimed |
| EP-3893054-B1 | PATTERN FORMING METHOD, PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, LAMINATE, AND DEVICE | FUJIFILM CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12609226-B2 | Composition, magnetic particle-containing film, and electronic component | FUJIFILM CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-3950753-B1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, INDUCTOR AND ANTENNA | FUJIFILM CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4692947-A1 | CHEMICAL SOLUTION AND PATTERNING METHOD | FUJIFILM Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12535732-B2 | Coloring composition, film, optical filter, solid-state imaging element and image display device | FUJIFILM CORPORATION (JP) | 2026-01-27 | — | — | US | disclosed |
| US-12529956-B2 | Resin composition, film, optical filter, solid-state imaging element, and image display device | FUJIFILM CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12528947-B2 | Infrared-absorbing composition, film, optical filter, solid-state imaging element, image display device, and infrared sensor | FUJIFILM CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-5385807-A | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0300410-B1 | Photopolymerizable composition | MITSUBISHI CHEM IND (JP) | 1994-10-26 | — | — | EP | disclosed |
| EP-0537630-A1 | Photopolymerizable composition | Mitsubishi Chemical Corporation (JP) | 1993-04-21 | — | — | EP | disclosed |
| EP-0520364-A1 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-30 | — | — | EP | disclosed |
| US-5049481-A | Merocyanine compound | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-17 | — | — | US | disclosed |
| US-4966830-A | Photopolymerizable composition | MITSUBISHI KASEI CORPORATION (JP) | 1990-10-30 | — | — | US | disclosed |
| EP-0300410-A2 | Photopolymerizable composition | Mitsubishi Chemical Corporation (JP) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12535732-B2 | Coloring composition, film, optical filter, solid-state imaging element and image display device | SF1, RER1, SFXN1 | SMN1; SMN2 562/4885MAPT 2813/4885CDK5 4782/4885 |
| US-12609226-B2 | Composition, magnetic particle-containing film, and electronic component | SMC2, SMC1A, SMC3 | SMN1; SMN2 276/4885MAPT 55/4885CDK5 3312/4885 |
| US-12529956-B2 | Resin composition, film, optical filter, solid-state imaging element, and image display device | PTGER1, CD40, FPR1 | SMN1; SMN2 1549/4885MAPT 1954/4885CDK5 4803/4885 |
| US-20080188474-A1 | e.g. 1-phenyl-N3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1H-1,2,4-triazole-3,5-diamine; receptor protein tyrosine kinase (AXL) antagonist; antiinflammatory, anticarcinogenic , antidiabetic agent; rheumatoid arthritis, vascular disease; breast, renal, endometrial, ovarian carcinoma, or myeloid leukemia | AXL, TYRO3, FLT3 | SMN1; SMN2 4804/4885MAPT 3845/4885CDK5 384/4885 |
| US-12528947-B2 | Infrared-absorbing composition, film, optical filter, solid-state imaging element, image display device, and infrared sensor | CRY2, CRY1, CHRM1 | SMN1; SMN2 1733/4885MAPT 2587/4885CDK5 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.